Struck, Joachim

Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay

Morgenthaler, N. G., Struck, J., Alonso, C., & Bergmann, A. (2005) · Clinical Chemistry

Neuropeptides and Animal PhysiologySepsis Diagnosis and Treatment

Cited by 399

Plasma Copeptin and the Risk of Diabetes Mellitus

Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation

Electrolyte and hormonal disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 299

Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients

Struck, J., Morgenthaler, N. G., & Bergmann, A. (2005) · Peptides

Electrolyte and hormonal disordersSepsis Diagnosis and Treatment

Cited by 240

C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study

Voors, A. A., von Haehling, S., Anker, S. D., Hillege, H. L., Struck, J., Hartmann, O., Bergmann, A., Squire, I., van Veldhuisen, D. J., Dickstein, K., et al. (2009) · European Heart Journal

Heart Failure Treatment and ManagementAcute Myocardial Infarction Research

Cited by 222

Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome

Enhörning, S., Struck, J., Wirfält, E., Hedblad, B., Morgenthaler, N. G., & Melander, O. (2011) · The Journal of Clinical Endocrinology & Metabolism

Adipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 177

Plasma Carboxy-Terminal Provasopressin (Copeptin): A Novel Marker of Insulin Resistance and Metabolic Syndrome

Saleem, U., Khaleghi, M., Morgenthaler, N. G., Bergmann, A., Struck, J., Mosley, T. H., & Kullo, I. J. (2009) · The Journal of Clinical Endocrinology & Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 161

Acute and long-term pituitary insufficiency in traumatic brain injury: a prospective single-centre study

Klose, M., Juul, A., Struck, J., Morgenthaler, N. G., Kosteljanetz, M., & Feldt‐Rasmussen, U. (2007) · Clinical Endocrinology

Pituitary Gland Disorders and TreatmentsTraumatic Brain Injury and Neurovascular Disturbances

Cited by 142

Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort

Meijer, E., Bakker, S. J. L., Halbesma, N., de Jong, P. E., Struck, J., & Gansevoort, R. T. (2010) · Kidney International

Chronic Kidney Disease and DiabetesElectrolyte and hormonal disorders

Cited by 123

Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

Abbasi, A., Corpeleijn, E., Gansevoort, R. T., Gans, R. O. B., Struck, J., Schulte, J., Hillege, H. L., van der Harst, P., Stolk, R. P., Navis, G., et al. (2014) · Diabetologia

Redox biology and oxidative stressAdipokines, Inflammation, and Metabolic Diseases

Cited by 27

The anorexigenic peptide neurotensin relates to insulin sensitivity in obese patients after BPD or RYGB metabolic surgery

von Loeffelholz, C., Gissey, L. C., Schumann, T., Henke, C., Kurzbach, A., Struck, J., Bergmann, A., Hanefeld, M., Schatz, U., Bornstein, S. R., et al. (2018) · International Journal of Obesity

Bariatric Surgery and OutcomesRegulation of Appetite and Obesity

Cited by 18